People In Brief
This article was originally published in The Gray Sheet
Executive Summary
The latest moves by movers and shakers in the medical device and diagnostics industries.
You may also be interested in...
New Products In Brief
Boston Scientific becomes the first with drug-eluting stents that are FDA-approved for use in patients experiencing a heart attack. More product news.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.